biote Corp. BTMD
1.09 USD +0.01 (+0.93%)
Nov 11, 2026, 9:48 AM EST
1.08 Day range 1.08
0.99 52-week range 2.90
- YTD
- -58.08%
- 1 year
- -58.24%
News
seekingalpha.com biote Corp. (BTMD) Q3 2026 Earnings Call Transcript biote Corp. ( BTMD ) Q3 2026 Earnings Call November 4, 2026 5:00 PM EST Company Participants Robert Peterson - Interim CEO, CFO & Chief Business Officer Conference Call Participants Szymon Serowiecki…
zacks.com biote Corp. (BTMD) Tops Q3 Earnings Estimates biote Corp. (BTMD) came out with quarterly earnings of $0.01 per share, beating the Zacks Consensus Estimate of a loss of $0.05 per share. This compares to earnings of $0.22 per share a year ago.
benzinga.com Biote Q3 2026 Earnings Call Transcript Biote (NASDAQ:BTMD) reported third-quarter financial results on Wednesday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you by…
businesswire.com Biote Reports Third Quarter 2026 Financial Results IRVING, Texas--(BUSINESS WIRE)--Biote (NASDAQ: BTMD), a leader in innovative hormone optimization and healthy aging solutions that advance the healthspan of our practitioners' patients, today…
benzinga.com 12 Health Care Stocks Moving In Wednesday's After-Market Session Gainers ENvue Medical (NASDAQ:FEED) shares rose 49.1% to $0.61 during Wednesday's after-market session. The market value of their outstanding shares is at $2.4 million. Omeros (NASDAQ:OMER) stock…
benzinga.com B. Riley Securities Maintains Neutral on Biote, Lowers Price Target to $1.5 B. Riley Securities analyst Jeff Van Sinderen maintains Biote (NASDAQ:BTMD) with a Neutral and lowers the price target from $2 to $1.5.
benzinga.com 12 Health Care Stocks Moving In Thursday's Intraday Session Gainers Creative Medical Tech (NASDAQ:CELZ) stock increased by 107.8% to $1.39 during Thursday's regular session. The company's market cap stands at $4.3 million. Ensysce Biosciences (NASDAQ:ENSC)…- benzinga.com 12 Health Care Stocks Moving In Wednesday's After-Market Session Gainers Creative Medical Tech (NASDAQ:CELZ) stock moved upwards by 31.4% to $0.88 during Wednesday's after-market session. The company's market cap stands at $4.2 million. Caris Life Sciences…
benzinga.com Biote Q2 EPS $(0.23) Misses $0.04 Estimate, Sales $44.232M Miss $46.148M Estimate Biote (NASDAQ:BTMD) reported quarterly losses of $(0.23) per share which missed the analyst consensus estimate of $0.04 by 675 percent. This is a 330 percent decrease over earnings of $0.10 per share…
benzinga.com Biote Reaffirms FY26 Guidance For Revenue Above $190M And Adjusted EBITDA Above $38M Biote reaffirmed its full year 2026 guidance for revenue above $190 million, Adjusted EBITDA above $38 million, and a return to procedure revenue growth in the second half of this year.
benzinga.com Biote Appoints CFO And Chief Business Officer Bob Peterson As Interim CEO And Director, Effective June 8; Bret Christensen Steps Down As CEO Biote (NASDAQ:BTMD), a leader in innovative hormone optimization and healthy aging solutions that advance the healthspan of our practitioners' patients, today announced that Bob Peterson, Chief…- benzinga.com Biote Q1 2026 Earnings Call: Complete Transcript
benzinga.com Earnings Scheduled For May 6, 2026 
benzinga.com Biote Q1 EPS $0.06 Beats $0.03 Estimate, Sales $44.935M Miss $46.023M Estimate Biote (NASDAQ:BTMD) reported quarterly earnings of $0.06 per share which beat the analyst consensus estimate of $0.03 by 100 percent. This is a 83.78 percent decrease over earnings of $0.37 per share…- benzinga.com Truist Securities Maintains Buy on Biote, Lowers Price Target to $4 Truist Securities analyst Gregory Fraser maintains Biote (NASDAQ:BTMD) with a Buy and lowers the price target from $5 to $4.
- benzinga.com B. Riley Securities Maintains Neutral on Biote, Lowers Price Target to $2 B. Riley Securities analyst Jeff Van Sinderen maintains Biote (NASDAQ:BTMD) with a Neutral and lowers the price target from $3 to $2.
benzinga.com Biote Q4 EPS $0.06 Beats $0.05 Estimate, Sales $46.408M Beat $46.190M Estimate Biote (NASDAQ:BTMD) reported quarterly earnings of $0.06 per share which beat the analyst consensus estimate of $0.05 by 20 percent. This is a 40 percent decrease over earnings of $0.10 per share…- benzinga.com Earnings Scheduled For March 11, 2026
benzinga.com Earnings Outlook For Biote - benzinga.com Biote Expects $1.3M Charge For Q4 Due To Recall Of Specific Lots Of Hormone Pellets; Additional Recall Costs In 2026 Estimated At $1.0M On January 26, 2026, F.H. Investments, Inc. ("Asteria Health"), a 503B manufacturer of compounded bioidentical hormones and wholly-owned subsidiary of biote Corp. (the "Company"), out of an abundance…
- benzinga.com Biote Affirms FY2025 Sales Guidance of $190.000M vs $192.670M Est Biote (NASDAQ:BTMD) affirms FY2025 sales outlook from $190.000 million to $190.000 million vs $192.670 million estimate.
- benzinga.com Biote Q3 EPS $0.22 Beats $0.07 Estimate, Sales $47.956M Beat $47.757M Estimate Biote (NASDAQ:BTMD) reported quarterly earnings of $0.22 per share which beat the analyst consensus estimate of $0.07 by 214.29 percent. This is a 33.33 percent decrease over earnings of $0.33 per…
benzinga.com Earnings Scheduled For November 5, 2025 - benzinga.com B. Riley Securities Downgrades Biote to Neutral, Lowers Price Target to $4 B. Riley Securities analyst Jeff Van Sinderen downgrades Biote (NASDAQ:BTMD) from Buy to Neutral and lowers the price target from $8 to $4.
benzinga.com 12 Health Care Stocks Moving In Thursday's Pre-Market Session - benzinga.com Biote Lowers FY2025 Sales Guidance from $202.000M-$208.000M to $190.000M vs $204.667M Est Biote (NASDAQ:BTMD) lowers FY2025 sales outlook from $202.000 million-$208.000 million to $190.000 million vs $204.667 million estimate.
- benzinga.com Biote Q2 EPS $0.10 Beats $0.06 Estimate, Sales $48.90M Miss $49.52M Estimate Biote (NASDAQ:BTMD) reported quarterly earnings of $0.10 per share which beat the analyst consensus estimate of $0.06 by 58.73 percent. This is a 152.63 percent increase over losses of $(0.19) per…
- benzinga.com Earnings Scheduled For August 6, 2025
benzinga.com 12 Health Care Stocks Moving In Friday's After-Market Session - benzinga.com 12 Health Care Stocks Moving In Tuesday's After-Market Session
- benzinga.com Biote Affirms FY2025 Sales Guidance of $202.00M-$208.00M vs $205.31M Est Biote (NASDAQ:BTMD) affirms FY2025 sales outlook from $202.00 million-$208.00 million to $202.00 million-$208.00 million vs $205.31 million estimate.
benzinga.com Biote Q1 EPS $0.37 Beats $0.07 Estimate, Sales $48.99M Beat $46.99M Estimate Biote (NASDAQ:BTMD) reported quarterly earnings of $0.37 per share which beat the analyst consensus estimate of $0.07 by 428.57 percent. This is a 716.67 percent increase over losses of $(0.06) per…- benzinga.com Earnings Scheduled For May 7, 2025
benzinga.com Why Meta Shares Are Trading Higher By Around 6%; Here Are 20 Stocks Moving Premarket - benzinga.com 12 Health Care Stocks Moving In Friday's Intraday Session
- benzinga.com 12 Health Care Stocks Moving In Thursday's Intraday Session
- benzinga.com Earnings Scheduled For March 12, 2025
benzinga.com Earnings Scheduled For November 12, 2024 - benzinga.com Earnings Scheduled For March 12, 2024 Companies Reporting Before The Bell • Aurora Mobile (NASDAQ:JG) is likely to report earnings for its fourth quarter.
- benzinga.com Earnings Scheduled For November 7, 2023 Companies Reporting Before The Bell • CorEnergy Infr Tr (NYSE:CORR) is estimated to report earnings for its third quarter.
- benzinga.com Earnings Scheduled For August 10, 2023 Companies Reporting Before The Bell • IDEX Biometrics (NASDAQ:IDBA) is estimated to report quarterly loss at $0.39 per share on revenue of $1.60 million.
- benzinga.com Earnings Scheduled For May 9, 2023 Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earnings at $0.17 per share on revenue of $440.16 million.
- benzinga.com Earnings Scheduled For March 28, 2023 Companies Reporting Before The Bell • Futu Holdings (NASDAQ:FUTU) is expected to report quarterly earnings at $0.70 per share on revenue of $237.12 million.
- benzinga.com Earnings Scheduled For November 8, 2022 Companies Reporting Before The Bell • Adtran (NASDAQ:ADTN) is likely to report quarterly earnings at $0.18 per share on revenue of $330.39 million.
- benzinga.com Why Nutanix Is Trading Higher By 16%; Here Are 33 Stocks Moving Premarket Gainers Bright Green Corporation (NASDAQ: BGXX) shares rose 63.8% to $2.26 in pre-market trading after gaining around 33% on Wednesday.
- benzinga.com Stocks That Hit 52-Week Lows On Wednesday On Wednesday, 26 companies achieved new lows for the year.
- benzinga.com Why Crypto-Related Companies Traded Higher; Here Are 72 Biggest Movers From Yesterday Gainers Applied Blockchain, Inc. (NASDAQ: APLD) shares climbed 100% to close at $2.12 on Tuesday after the company reported a 200-megawatt five-year hosting contract with Marathon Digital Holdings…
- benzinga.com Benzinga's Top Ratings Upgrades, Downgrades For June 24, 2022 Upgrades
- benzinga.com Stocks That Hit 52-Week Lows On Thursday On Thursday, 216 stocks hit new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Wednesday On Wednesday, 329 companies hit new 52-week lows.